This report presents a detailed visual analysis of lung cancer temporal and spatial trends in Nevada, from 2015 to 2021, using data tables and graphs to highlight key patterns and comparisons. Despite a discrete reduction in the observed lung cancer incidence and mortality, it remains a significant public health concern in Nevada, contributing heavily to cancer-related morbidity and mortality. In 2021 the state’s lung cancer age-adjusted incidence rate of 43.7 per 100,000 people, ranked the 14th highest nationally, while the screening rate was among the lowest in the country at just 1.4%, ranking at 47th out of 51 (including all U.S. states and the District of Columbia). This report compares Nevada’s lung cancer data to national averages, illustrating regional variations influenced by demographics, risk factors, access to healthcare, and screening practices. Data limitations, such as the inherent lag in cancer reporting, are noted to provide context for the presented findings.